Skip to content

Effectiveness of High-intensity Aerobic Interval Training on Impairments and Activity Limitations in the Acute Phase of Stroke in Benin

Is High-intensity Aerobic Interval Training Appropriate for Recovering Impairments and Activity Limitations in the Acute Phase of Stroke? A Randomized Controlled Trial in Benin

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06179173
Enrollment
40
Registered
2023-12-21
Start date
2023-01-01
Completion date
2024-04-30
Last updated
2023-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Acute

Brief summary

This clinical trial aims to examine the effects of combining HIIT on a semi-recumbent cycle ergometer (HIIT-RCE) with conventional physiotherapy on impairments and activity limitations in early subacute stroke. We hypothesized that HIIT combined with conventional physiotherapy would be more effective than conventional physiotherapy in improving workload capacity.

Interventions

OTHERHIIT-RCE

High-intensity interval training on semi-recumbent cycle ergometer

OTHERConventional physiotherapy

Conventional physiotherapy

Sponsors

Université de Parakou
CollaboratorOTHER
Hasselt University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

People with the diagnosis of stroke were screened and recruited within the first-month after the stroke onset according to the following criteria 1. first episode from an ischemic or hemorrhagic stroke confirmed by CT scan; 2. muscle strength of the affected leg defined by Motricity Index between 14 and 19, i.e., between 2 and 4 on the Medical Research Council scale; 3. modified Ashworth score of 0 or 1, indicating no spasticity or slight spasticity over the affected lower limb, respectively 4. able to walk at least 5 meters independently with or without assistive devices and understand simple instructions; 5. resident in Parakou or its surroundings 6. wish to participate in the hospital program

Exclusion criteria

Patients whose medical records reported 1. uncontrolled cardiac arrhythmias (e.g. atrial fibrillation, ventricular tachycardia), heart failure, or recent myocardial infarction, arteriopathy, 2. primary orthopedic conditions (e.g., fractures, active rheumatoid arthritis), 3. other neurological diseases (such as Parkinson's disease and Alzheimer's disease), (4) patients unable to perform a graded exercise test, i.e., unable to reach the target cadence of 50 rpm or exercise-induced asthma

Design outcomes

Primary

MeasureTime frameDescription
Workload capacityAt enrolment (T0), After 6 weeks of intervention (T1), 3 months (T2) and 6 months (T3) after interventionA progressive intensity maximal effort cycling test will be performed in a semi-recumbent ergometer cycle (SOLE R90) to determine each participant's peak workload (in watts).

Secondary

MeasureTime frameDescription
The EQ-5D-5LAt enrolment (T0), After 6 weeks of intervention (T1), 3 months (T2) and 6 months(T3) after interventionThe EQ-5D-5L is a self-assessed, health-related, quality of life questionnaire validated for acute stroke. It has 5 domains (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) of 5 items each, and scores range from 0 (best quality of life) to 1 (worst quality of life).
The Berg Balance Scale (BBS),At enrolment (T0), After 6 weeks of intervention (T1), 3 months (T2) and 6 months (T3) after interventionThe BBS will be used to assess balance impairment. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function. The minimum score is 0 and the maximum score is 56. A score of 56 indicates functional balance and a score \< 45 indicates a higher risk of falling.
The 6-minute walk test (6MWT)At enrolment (T0), After 6 weeks of intervention (T1), 3 months (T2) and 6 months (T3) after interventionThe 6MWT is a measure of walking endurance. 35,36 It assesses the distance a participant can walk as fast as possible for 6 min on a 30 m straight line with the option to stop for fatigue at any point.
The 10-meter Walk Test (10mWT)At enrolment (T0), After 6 weeks of intervention (T1), 3 months (T2) and 6 months (T3) after interventionThe 10mWT is a performance measure used to assess walking speed in meters per second over the middle 10 meters of a 14-meter course.
The 5-Repetition Sit-To-Stand test (5R-STS)At enrolment (T0), After 6 weeks of intervention (T1), 3 months (T2) and 6 months (T3) after interventionThe 5R-STS test measures the time to complete five repetitions of the sit-to-stand maneuver. Participants unable to complete five repetitions within 1-min will be given a score of 60 s.

Countries

Benin

Contacts

Primary ContactDominique Hansen, PhD
dominique.hansen@uhasselt.be+32497875866
Backup ContactElogni R Amanzonwé, MSc, PhD student
renaud.amanzonwe@uhasselt.be+22995607820

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026